The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease

Brain Research Reviews

Volumn 27, Issue 2, 1998, Pages 119-142

  Beffert, Uwe ^a,b   Danik, Marc ^b   Krzywkowski, Pascale ^b   Ramassamy, Charles ^b   Berrada, Fouad ^a   Poirier, Judes ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; Apolipoprotein D; Apolipoprotein E; Apolipoprotein E receptor 2; Apolipoprotein J; Brain; Cholinergic dysfunction; Low density lipoprotein receptor; Low density lipoprotein receptor related protein; Neuronal plasticity; Very low density lipoprotein receptor

Indexed keywords

APOLIPOPROTEIN C; APOLIPOPROTEIN D; APOLIPOPROTEIN E; CLUSTERIN; LOW DENSITY LIPOPROTEIN RECEPTOR; VERY LOW DENSITY LIPOPROTEIN;

ALZHEIMER DISEASE; CHOLINERGIC TRANSMISSION; LIPOPROTEIN METABOLISM; MARKER GENE; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NEUROBIOLOGY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE;

EID: 0031800003     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(98)00008-3     Document Type: Article

References (301)

1. Adroer R., Santacruz P., Blesa R., Lopez-Pousa S., Ascaso C., Oliva R. Apolipoprotein E4 allele frequency in Spanish Alzheimer and control cases. Neurosci. Lett. 189:1995;182-186.
2. al-Chalabi A., Enayat Z.E., Bakker M.C., Sham P.C., Ball D.M., Shaw C.E., Lloyd C.M., Powell J.F., Leigh P.N. Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. Lancet. 347:1996;159-160.
3. Alaupovic P. Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA- and ApoB-containing lipoprotein families. Prog. Lipid Res. 30:1991;105-138.
4. Amouyel P., Vidal O., Launay J.M., Laplanche J.L. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies. Lancet. 344:1994;1315-1318.
5. Anderson R., Higgins G.A. Absence of central cholinergic deficits in apoE knockout mice. Psychopharmacology. 132:1997;135-144.
6. Andersson M., Aberg F., Teclebrhan H., Edlund C., Appelkvist E.L. Age-dependent modifications in the metabolism of mevalonate pathway lipids in rat brain. Mech. Ageing Dev. 85:1995;1-14.
7. Anouti A., Schmidt K., Lyons K.E., Hubble J.P., Schellenberg G.D., Golbe L.I., Lang A.E., Galvez-Jimenez N., Hershey L., Koller W.C. Normal distribution of apolipoprotein E alleles in progressive supranuclear palsy. Neurology. 46:1996;1156-1157.
8. Arendt T., Schindler C., Bruckner M.K., Eschrich K., Bigl V., Zedlick D., Marcova L. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein ε4 allele. J. Neurosci. 17:1997;516-529.
9. Avramopoulos D., Mikkelsen M., Vassilopoulos D., Grigoriadou M., Petersen M.B. Apolipoprotein E allele distribution in parents of Down's syndrome children. Lancet. 347:1996;862-865.
10. Basun H., Grut M., Winblad B., Lannfelt L. Apolipoprotein epsilon-4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci. Lett. 183:1995;32-34.
11. Beffert U., Aumont N., Dea D., Lussier-Cacan S., Davignon J., Poirier J. β-amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons. J. Neurochem. 70:1998;1458-1466.
12. Beffert U., Poirier J. Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease. Ann. NY Acad. Sci. 777:1996;166-174.
13. Bell M.D., Lopez-Gonzalez R., Lawson L., Hughes D., Fraser I., Gordon S., Perry V.H. Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS. J. Neurocyt. 23:1994;605-613.
14. Bellosta S., Nathan B.P., Orth M., Dong L.M., Mahley R.W., Pitas R.E. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produce differential effects on neurite outgrowth. J. Biol. Chem. 270:1995;27063-27071.
15. Benjamin R., Leake A., Edwardson J.A., McKeith I.G., Ince P.G., Perry R.H., Morris C.M. Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet. 343:1994;1565-1565.
16. Benjamin R., Leake A., Ince P.G., Perry R.H., McKeith I.G., Edwardson J.A., Morris C.M. Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body and Alzheimer's disease. Neurodegeneration. 4:1995;443-448.
17. Berr C., Hauw J.J., Delaere P., Duyckaerts C., Amouyel P. Apolipoprotein E allele epsilon-4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease. Neurosci. Lett. 178:1994;221-224.
18. Bertrand P., Poirier J., Oda T., Finch C.E., Pasinetti G.M. Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer's disease. Mol. Brain Res. 33:1995;174-178.
19. Bessesen D.H., Richards C.L., Etienne J., Goers J.W., Eckel R.H. Spinal cord of the rat contains more lipoprotein lipase than other brain regions. J. Lipid Res. 34:1993;229-238.
20. Betard C., Robitaille Y., Gee M., Tiberghien D., Larrivee D., Roy P., Mortimer J.A., Gauvreau D. Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuroreport. 5:1994;1893-1896.
21. Blennow K., Hesse C., Fredman P. Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease. Neuroreport. 5:1994;2534-2536.
22. Blesa R., Adroer R., Santacruz P., Ascaso C., Tolosa E., Oliva R. High apolipoprotein E epsilon 4 allele frequency in age-related memory decline. Ann. Neurol. 39:1996;548-551.
23. Blusztajn J.K., Liscovitch M., Mauron C., Richardson U.I., Wurtman R.J. Phosphatidylcholine as a precursor of choline for acetylcholine synthesis. J. Neural Trans. Suppl. 24:1987;247-259.
24. Borghini I., Barja F., Pometta D., James R.W. Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim. Biophys. Acta. 1255:1995;192-200.
25. Boyles J.K., Notterpek L.M., Anderson L.J. Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I. J. Biol. Chem. 265:1990;17805-17815.
26. Boyles J.K., Notterpek L.M., Wardell M.R., Rall S.C. Jr. Identification, characterization, and tissue distribution of apolipoprotein D in the rat. J. Lipid Res. 31:1990;2243-2256.
27. Boyles J.K., Pitas R.E., Wilson E., Mahley R.W., Taylor J.M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76:1985;1501-1513.
28. Boyles J.K., Zoellner C.D., Anderson L.J., Kosik L.M., Pitas R.E., Weisgraber K.H., Hui D.Y., Mahley R.W., Gebicke-Haerter P.J., Ignatius M.J., Shooter E.M. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J. Clin. Invest. 83:1989;1015-1031.
29. Brandes C., Novak S., Stockinger W., Herz J., Schneider W.J., Nimpf J. Avian and murine LR8B and human apolipoprotein E receptor 2: differentially spliced products from corresponding genes. Genomics. 42:1997;185-191.
30. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science. 232:1986;34-47.
31. Bu G., Geuze H.J., Strous G.J., Schwartz A.L. 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein. EMBO J. 14:1995;2269-2280.
32. Bu G., Maksymovitch E.A., Nerbonne J.M., Schwartz A.L. Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J. Biol. Chem. 269:1994;18521-18528.
33. R.M. Burton, H.C., Agrawal, The turnover of protein and lipid components of myelin membranes, in: R.M. Burton, L. Packer (Eds.), Biomembranes: Lipids, Proteins and Receptors, BI-Science Publications, Webster Groves, MO, 1975, pp. 27-50.
34. Chartier-Harlin M.C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rossor M., Roques P., Hardy J., Mullan M. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature. 353:1991;844-846.
35. Chartier-Harlin M.C., Parfitt M., Legrain S., Perez-Tur J., Brousseau T., Evans A., Berr C., Vidal O., Roques P., Gourlet V., Fruchart J.C., Delacourte A., Rossor M., Amouyel P. Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum. Mol. Genet. 3:1994;569-574.
36. Choi-Miura N.H., Ihara Y., Fukuchi K., Takeda M., Nakano Y., Tobe T., Tomita M. SP-40,40 is a constituent of Alzheimer's amyloid. Acta Neuropathol. 83:1992;260-264.
37. Christie R.H., Chung H., Rebeck G.W., Strickland D., Hyman B.T. Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:1996;491-498.
38. Christie R.H., Freeman M., Hyman B.T. Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's disease. Am. J. Pathol. 148:1996;399-403.
39. Chung H., Roberts C.T., Greenberg S., Rebeck G.W., Christie R., Wallace R., Jacob H.J., Hyman B.T. Lack of association of trinucleotide repeat polymorphisms in very-low-density lipoprotein receptor gene with Alzheimer's disease. Ann. Neurol. 39:1996;800-803.
40. Clair D.S., Rennie M., Slorach E., Norrman J., Yates C., Carothers A. Apolipoprotein E ε-4 allele is a risk factor for familial and sporadic presenile Alzheimer's disease in both homozygote and heterozygote carriers. J. Med. Genet. 32:1995;642-644.
41. Corder E.H., Saunders A.M., Risch N.J., Strittmatter W.J., Schmechel D.E., Gaskell P.C. Jr., Rimmler J.B., Locke P.A., Conneally P.M., Schmader K.E., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7:1994;180-184.
42. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Roses A.D., Pericak-Vance M.A., Small G.W., Haines J.L. The apolipoprotein E ε4 allele and sex-specific risk of Alzheimer's disease. JAMA. 273:1995;373-374.
43. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
44. Danik M., Chabot J.G., Hassan-Gonzalez D., Suh M., Quirion R. Localization of sulfated glycoprotein-2/clusterin mRNA in the rat brain by in situ hybridization. J. Comp. Neurol. 334:1993;209-227.
45. Danik M., Chabot J.G., Mercier C., Benabid A.L., Chauvin C., Quirion R., Suh M. Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell death. Proc. Natl. Acad. Sci. U.S.A. 88:1991;8577-8581.
46. Datta S., Li W.H., Ghosh I., Luo C.C., Chan L. Structure and expression of dog apolipoprotein C-II and C-III mRNAs. Implications for the evolution and functional constraints of apolipoprotein structure. J. Biol. Chem. 262:1987;10588-10593.
47. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
48. Day J.R., Albers J.J., Gilbert T.L., Whitmore T.E., McConathy W.J., Wolfbauer G. Purification and molecular cloning of human apolipoprotein F. Biochem. Biophys. Res. Commun. 203:1994;1146-1151.
49. de Silva H.V., Stuart W.D., Duvic C.R., Wetterau J.R., Ray M.J., Ferguson D.G., Albers H.W., Smith W.R., Harmony J.A. A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins. J. Biol. Chem. 265:1990;13240-13247.
50. Dehouck B., Dehouck M.P., Fruchart J.C., Cecchelli R. Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes. J. Cell Biol. 126:1994;465-473.
51. Diedrich J.F., Minnigan H., Carp R.I., Whitaker J.N., Race R., Frey W.2., Haase A.T. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J. Virol. 65:1991;4759-4768.
52. Drayna D., Fielding C., McLean J., Baer B., Castro G., Chen E., Comstock L., Henzel W., Kohr W., Rhee L., Wion K., Lawn K. Cloning and expression of human apolipoprotein D cDNA. J. Biol. Chem. 261:1986;16535-16539.
53. Duguid J.R., Bohmont C.W., Liu N.G., Tourtellotte W.W. Changes in brain gene expression shared by scrapie and Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 86:1989;7260-7264.
54. Egensperger R., Bancher C., Kosel S., Jellinger K., Mehraein P., Graeber M.B. The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions. Biochem. Biophys. Res. Commun. 224:1996;484-486.
55. Elshourbagy N.A., Liao W.S., Mahley R.W., Taylor J.M. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. Natl. Acad. Sci. U.S.A. 82:1985;203-207.
56. Elshourbagy N.A., Walker D.W., Boguski M.S., Gordon J.I., Taylor J.M. The nucleotide and derived amino acid sequence of human apolipoprotein A-IV mRNA and the close linkage of its gene to the genes of apolipoproteins A-I and C-III. J. Biol. Chem. 261:1986;1998-2002.
57. Fagan A.M., Bu G., Sun Y., Daugherty A., Holtzman D.M. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J. Biol. Chem. 271:1996;30121-30125.
58. M.R. Farlow, D.K. Lahiri, J. Poirier, J. Davignon, S. Hui, Apolipoprotein E genotype and gender influence response to tacrine therapy, Ann. NY Acad. Sci. (1996) 101-110.
59. Farrer L.A., Cupples L.A., Haines J.L., Hyman B.T., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. JAMA. 278:1997;1349-1356.
60. Freeman M.W. Scavenger receptors in atherosclerosis. Curr. Opin. Hematol. 4:1997;41-47.
61. Frisoni G.B., Govoni S., Geroldi C., Bianchetti A., Calabresi L., Franceschini G., Trabucchi M. Gene dose of the epsilon-4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann. Neurol. 37:1995;596-604.
62. Fujimoto K., Fukagawa K., Sakata T., Tso P. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J. Clin. Invest. 91:1993;1830-1833.
63. Galasko D., Saitoh T., Xia Y., Thal L.J., Katzman R., Hill L.R., Hansen L. The apolipoprotein E allele epsilon-4 is overexpressed in patients with Lewy body variant of Alzheimer's disease. Neurology. 44:1994;1950-1951.
64. Gao B., Virmani M., Romm E., Lazar-Wesley E., Sakaguchi K., Appella E., Kunos G., Takacs L. Sequence of a cDNA encoding bovine apolipoprotein H. Gene. 126:1993;287-288.
65. Garden G.A., Bothwell M., Rubel E.W. Lack of correspondence between mRNA expression for a putative cell death molecule (SGP-2) and neuronal cell death in the central nervous system. J. Neurobiol. 22:1991;590-604.
66. Gearing M., Mori H., Mirra S.S. A beta-peptide length and apolipoprotein E genotype in Alzheimer's disease. Ann. Neurol. 39:1996;395-399.
67. Gearing M., Schneider J.A., Robins R.S., Hollister R.D., Mori H., Games D., Hyman B.T., Mirra S.S., Robbins R.S. Regional variation in the distribution of apolipoprotein E and A beta in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 54:1995;833-841.
68. Giulian D., Vaca K. Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke. 24:1993;184-190.
69. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M.A., Roses A.D., Williamson R., Rossor M., Owen M., Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
70. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature. 343:1990;425-430.
71. Gomez-Isla T., West H.L., Rebeck G.W., Harr S.D., Growdon J.H., Locascio J.J., Perls T.T., Lipsitz L.A., Hyman B.T. Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease. Ann. Neurol. 39:1996;62-70.
72. Goodrum J.F. Cholesterol synthesis is down-regulated during regeneration of peripheral nerve. J. Neurochem. 54:1990;1709-1715.
73. Goodrum J.F., Bouldin T.W., Zhang S.H., Maeda N., Popko B. Nerve regeneration and cholesterol reutilization occur in the absence of apolipoproteins E and A-I in mice. J. Neurochem. 64:1995;408-416.
74. Gordon I., Grauer E., Genis I., Sehayek E., Michaelson D.M. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199:1995;1-4.
75. Grewal R.P., Yoshida T., Finch C.E., Morgan T.E. Scavenger receptor mRNAs in rat brain microglia are induced by kainic acid lesioning and by cytokines. Neuroreport. 8:1997;1077-1081.
76. Growdon J.H., Locascio J.J., Corkin S., Gomez-Isla T., Hyman B.T. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology. 47:1996;444-448.
77. Hachinski V., Graffagnino C., Beaudry M., Bernier G., Buck C., Donner A., Spence J.D., Doig G., Wolfe B.M.J. Lipids and stroke - a paradox resolved. Arch. Neurol. 53:1996;303-308.
78. Han S.H., Einstein G., Weisgraber K.H., Strittmatter W.J., Saunders A.M., Pericak-Vance M.A., Roses A.D., Schmechel D.E. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J. Neuropathol. Exp. Neurol. 53:1994;535-544.
79. Han S.H., Hulette C., Saunders A.M., Einstein G., Pericak-Vance M.A., Strittmatter W.J., Roses A.D., Schmechel D.E. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp. Neurol. 128:1994;13-26.
80. Handelmann G.E., Boyles J.K., Weisgraber K.H., Mahley R.W., Pitas R.E. Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J. Lipid Res. 33:1992;1677-1688.
81. Hansen L., Salmon D., Galasko D., Masliah E., Katzman R., DeTeresa R., Thal L., Pay M.M., Hofstetter R., Klauber M., Rice V., Butters N., Alford M. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology. 40:1990;1-8.
82. Hansen L.A., Galasko D., Samuel W., Xia Y., Chen X.H., Saitoh T., Chen X. Apolipoprotein-E ε4 is associated with increased neurofibrillary pathology in the Lewy body variant of Alzheimer's disease. Neurosci. Lett. 182:1994;63-65.
83. Hardy J. Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease. Am. J. Med. Gen. 60:1995;456-460.
84. Hardy J., Crook R., Perry R., Raghavan R., Roberts G. ApoE genotype and Down's syndrome. Lancet. 343:1994;979-980.
85. Hardy J., Crook R., Prihar G., Roberts G., Raghavan R., Perry R. Senile dementia of the Lewy body type has an apolipoprotein epsilon-4 allele frequency intermediate between controls and Alzheimer's disease. Neurosci. Lett. 182:1994;1-2.
86. Hardy J., Houlden H., Collinge J., Kennedy A., Newman S., Rossor M., Lannfelt L., Lilius L., Winblad B., Crook R., Duff K. ApoE genotype and Alzheimer's disease. Lancet. 342:1993;737-738.
87. Harr S.D., Uint L., Hollister R., Hyman B.T., Mendez A.J. Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J. Neurochem. 66:1996;2429-2435.
88. Harrington C.R., Anderson J.R., Chan K.K. Apolipoprotein E type epsilon 4 allele frequency is not increased in patients with sporadic inclusion-body myositis. Neurosci. Lett. 183:1995;35-38.
89. Harrington C.R., Louwagie J., Rossau R., Vanmechelen E., Perry R.H., Perry E.K., Xuereb J.H., Roth M., Wischik C.M. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am. J. Pathol. 145:1994;1472-1484.
90. Harrington C.R., Roth M., Xuereb J.H., McKenna P.J., Wischik C.M. Apolipoprotein E type epsilon 4 allele frequency is increased in patients with schizophrenia. Neurosci. Lett. 202:1995;101-104.
91. Hofmann S.L., Russell D.W., Goldstein J.L., Brown M.S. mRNA for low density lipoprotein receptor in brain and spinal cord of immature and mature rabbits. Proc. Natl. Acad. Sci. U.S.A. 84:1987;6312-6316.
92. Holtzman D.M., Pitas R.E., Kilbridge J., Nathan B., Mahley R.W., Bu G.J., Schwartz A.L. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived cell line. Proc. Natl. Acad. Sci. U.S.A. 92:1995;9480-9484.
93. Hyman B.T. Apolipoprotein E genotype: utility in clinical practice in Alzheimer's disease. J. Am. Geriatr. Soc. 44:1996;1469-1471.
94. B.T. Hyman, G.W. Rebeck, R. Christie, K. Page, M. Irizarry, D.K. Strickland, Apolipoprotein E and apolipoprotein E receptors in the central nervous system: relationship with Alzheimer's disease. In: A.D. Roses, K.H. Weisgraber, Y. Christen (Eds.), Apolipoprotein E and Alzheimer's disease, Springer, Berlin, 1996, pp. 97-102.
95. Hyman B.T., Van Hoesen G.W., Kromer L.J., Damasio A.R. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann. Neurol. 20:1986;472-481.
96. Hyman B.T., Van Horsen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science. 225:1984;1168-1170.
97. Hyman B.T., West H.L., Rebeck G.W., Buldyrev S.V., Mantegna R.N., Ukleja M., Havlin S., Stanley H.E. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc. Natl. Acad. Sci. U.S.A. 92:1995;3586-3590.
98. Hyman B.T., West H.L., Rebeck G.W., Lai F., Mann D.M.A. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype. Arch. Neurol. 52:1995;373-378.
99. Ibarreta D., Gomez-Isla T., Portera-Sanchez A., Parrilla R., Ayuso M.S. Apolipoprotein E genotype in Spanish patients of Alzheimer's or Parkinson's disease. J. Neurol. Sci. 134:1995;146-149.
100. Ignatius M.J., Gebicke-Harter P.J., Skene J.H., Schilling J.W., Weisgraber K.H., Mahley R.W., Shooter E.M. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc. Natl. Acad. Sci. U.S.A. 83:1986;1125-1129.
101. Ignatius M.J., Shooter E.M., Pitas R.E., Mahley R.W. Lipoprotein uptake by neuronal growth cones in vitro. Science. 236:1987;959-962.
102. K. Ikeda, T. Aizawa, S. Hagas, N. Otsuka, M. Mizuguchi, Y. Namba, R. Machinami, S.U. Kim, T. Yamamoto, Very low density lipoprotein receptor and Alzheimer's disease, in: A.D. Roses, K.H. Weisgraber, Y. Christen (Eds.), Apolipoprotein E and Alzheimer's Disease, Springer, Berlin, 1996, pp. 74-96.
103. Illingworth D.R., Glover J. Lecithin: cholesterol acyl transferase activity in human cerebrospinal fluid. Biochim. Biophys. Acta. 220:1970;610-613.
104. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92:1993;883-893.
105. Ishibashi S., Herz J., Maeda N., Goldstein J.L., Brown M.S. The two-receptor model of lipoprotein clearance: tests of the hypothesis in 'knockout' mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc. Natl. Acad. Sci. U.S.A. 91:1994;4431-4435.
106. Ishiguro M., Imai Y., Kohsaka S. Expression and distribution of low density lipoprotein receptor-related protein mRNA in the rat central nervous system. Mol. Brain Res. 33:1995;37-46.
107. Itoh Y., Yamada M. Apolipoprotein E and the neuropathology of dementia. New Engl. J. Med. 334:1996;599-600.
108. Jackson R.L., Morrisett J.D., Sparrow J.T., Segrest J.P., Pownall H.J., Smith L.C., Hoff H.F., Gotto A.M. Jr. The interaction of apolipoprotein-serine with phosphatidylcholine. J. Biol. Chem. 249:1974;5314-5320.
109. Jacobsen L., Madsen P., Moestrup S.K., Lund A.H., Tommerup N., Nykjaer A., Sottrupjensen L., Gliemann J., Petersen C.M. Molecular characterization of a novel human hybrid-type receptor that binds the alpha(2)-macroglobulin receptor-associated protein. J. Biol. Chem. 271:1996;31379-31383.
110. Jenne D.E., Tschopp J. Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends Biochem. Sci. 17:1992;154-159.
111. Johnson R.C., Shah S.N. Cholesterol ester metabolizing enzymes in human brain: properties, subcellular distribution and relative levels in various diseased conditions. J. Neurochem. 31:1978;895-902.
112. Jones O.T., McNamee M.G. Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor. Biochemistry. 27:1988;2364-2374.
113. Jones S.E., Meerabux J.M., Yeats D.A., Neal M.J. Analysis of differentially expressed genes in retinitis pigmentosa retinas. Altered expression of clusterin mRNA. FEBS Lett. 300:1992;279-282.
114. Jonsson E., Lannfelt L., Engvall B., Sedvall G. Lack of association between schizophrenia and the apolipoprotein E-epsilon-4 allele. Eur. Arch. Psychiatry Clin. Neurosci. 246:1996;182-184.
115. Joober R., Rouleau G., Fon E., Lal S., Palmour R., Bloom D., Labelle A., Benkelfat C. Apolipoprotein E genotype in schizophrenia. Am. J. Med. Gen. 67:1996;235-235.
116. Jordan C.A., Watkins B.A., Kufta C., Dubois-Dalcq M. Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent. J. Virol. 65:1991;736-742.
117. Jung-Testas I., Weintraub H., Dupuis D., Eychenne B., Baulieu E.E., Robel P. Low density lipoprotein-receptors in primary cultures of rat glial cells. J. Steroid Biochem. Mol. Biol. 42:1992;597-605.
118. Kamboh M.I. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease. Hum. Biol. 67:1995;195-215.
119. Katzman R., Galasko D., Saitoh T., Thal L.J., Hansen L. Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease. Brain and Cognition. 28:1995;259-265.
120. Kawanishi C., Suzuki K., Odawara T., Iseki E., Onishi H., Miyakawa T., Yamada Y., Kosaka K., Kondo N., Yamamoto T. Neuropathological evaluation and apolipoprotein E gene polymorphism analysis in diffuse Lewy body disease. J. Neurol. Sci. 136:1996;140-142.
121. Kim D.H., Iijima H., Goto K., Sakai J., Ishii H., Kim H.J., Suzuki H., Kondo H., Saeki S., Yamamoto T. Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J. Biol. Chem. 271:1996;8373-8380.
122. Koller W.C., Glatt S.L., Hubble J.P., Paolo A., Troster A.I., Handler M.S., Horvat R.T., Martin C., Schmidt K., Karst A., Wijsman E.M., Yu C.E., Schellenberg G.D. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann. Neurol. 37:1995;242-245.
123. Koudinov A.R., Koudinova N.V., Kumar A., Beavis R.C., Ghiso J. Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid - association with high-density lipoproteins. Biochem. Biophys. Res. Commun. 223:1996;592-597.
124. Kounnas M.Z., Loukinova E.B., Stefansson S., Harmony J.A., Brewer B.H., Strickland D.K., Argraves W.S. Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J. Biol. Chem. 270:1995;13070-13075.
125. Kowal R.C., Herz J., Weisgraber K.H., Mahley R.W., Brown M.S., Goldstein J.L. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J. Biol. Chem. 265:1990;10771-10779.
126. Krieger M., Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63:1994;601-637.
127. P. Krzywkowski, J. Gagne, C. Chabot, S. Kar, J. Rochford, G. Massicotte, J. Poirier, Cholinergic systems and long-term potentiation in memory impaired apolipoprotein E deficient mice (submitted for publication).
128. Kunisada T., Higuchi K., Aota S., Takeda T., Yamagishi H. Molecular cloning and nucleotide sequence of cDNA for murine senile amyloid protein: nucleotide substitutions found in apolipoprotein A-II cDNA of senescence accelerated mouse (SAM). Nucleic Acids Res. 14:1986;5729-5740.
129. Kuusisto J., Koivisto K., Kervinen K., Mykkanen L., Helkala E.-L., Vanhanen M., Hanninen T., Pyorala K., Kesaniemi Y.A., Riekkinen P., Laakso M. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population-based study. B.M.J. 309:1994;636-638.
130. Landen M., Hesse C., Fredman P., Regland B., Wallin A., Blennow K. Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform. Dementia. 7:1996;273-278.
131. Landen M., Thorsell A., Wallin A., Blennow K. The apolipoprotein E allele epsilon-4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimers disease. J. Neurol. Neurosurg. Psychiatry. 61:1996;352-356.
132. Lauer S.J., Walker D., Elshourbagy N.A., Reardon C.A., Levy-Wilson B., Taylor J.M. Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene. J. Biol. Chem. 263:1988;7277-7286.
133. LeBlanc A.C., Poduslo J.F. Regulation of apolipoprotein E gene expression after injury of the rat sciatic nerve. J. Neurosci. Res. 25:1990;162-171.
134. Lee K.S., Stanford E.J., Cotman C.W., Lynch G.S. Ultrastructural evidence for bouton proliferation in the partially deafferented dentate gyrus of the adult rat. Exp. Brain Res. 29:1977;475-485.
135. Lehtimäki T., Pïrttila T., Mehta P.D., Wisniewski H.M., Frey H., Nikkari T. Apolipoprotein E (apoE) polymorphism and its influence on apoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease. Hum. Genet. 95:1995;39-42.
136. Lehtovirta M., Laakso M.P., Soininen H., Helisalmi S., Mannermaa A., Helkala E.L., Partanen K., Ryynanen M., Vainio P., Hartikainen P., Riekkinen P.J. Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience. 67:1995;65-72.
137. Lehtovirta M., Soininen H., Helisalmi S., Mannermaa A., Helkala E.L., Hartikainen P., Hanninen T., Ryynanen M., Riekkinen P.J. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology. 46:1996;413-419.
138. Lehtovirta M., Soininen H., Laakso M.P., Partanen K., Helisalmi S., Mannermaa A., Ryynanen M., Kuikka J., Hartikainen P., Riekkinen P.J. Sr. SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E ε4 allele. J. Neurol. Neurosurg. Psychiatry. 60:1996;644-649.
139. Lendon C.L., Talbot C.J., Craddock N.J., Han S.W., Wragg M., Morris J.C., Goate A.M. Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci. Lett. 222:1997;187-190.
140. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K., Crowley A.C., Fu Y.-H., Guenette S.Y., Galas D., Nemens E., Wijsman E.M., Bird T.D., Schellenberg G.D., Tanzi R.E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977.
141. Lippa C.F., Smith T.W., Saunders A.M., Crook R., Pulaski-Salo D., Davies P., Hardy J., Roses A.D., Dickson D. Apolipoprotein E genotype and Lewy body disease. Neurology. 45:1995;97-103.
142. Lorent K., Overbergh L., Moechars D., Destrooper B., Vanleuven F., Vandenberghe H. Expression in mouse embryos and in adult mouse brain of three members of the amyloid precursor protein family, of the alpha-2-macroglobulin receptor/low density lipoprotein receptor-related protein and of its ligands apolipoprotein E, lipoprotein lipase, alpha-2-macroglobulin and the 40,000 molecular weight receptor-associated protein. Neuroscience. 65:1995;1009-1025.
143. Lucotte G., David F., Visvikis S., Leininger-Muller B., Siest G., Babron M.C., Couderc R. Apolipoprotein E-ε4 allele and Alzheimer's disease. Lancet. 342:1993;1309-1309.
144. Luo C.C., Li W.H., Chan L. Structure and expression of dog apolipoprotein A-I, E, and C-I mRNAs: implications for the evolution and functional constraints of apolipoprotein structure. J. Lipid Res. 30:1989;1735-1746.
145. Lynch G., Gall C., Rose G., Cotman C. Changes in the distribution of the dentate gyrus associational system following unilateral or bilateral entorhinal lesions in the adult rat. Brain Res. 110:1976;57-71.
146. Lynch G., Matthews D.A., Mosko S., Parks T., Cotman C. Induced acetylcholinesterase-rich layer in rat dentate gyrus following entorhinal lesions. Brain Res. 42:1972;311-318.
147. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
148. Mahley R.W., Innerarity T.L. Lipoprotein receptors and cholesterol homeostasis. Biochim. Biophys. Acta. 737:1983;197-222.
149. Mahley R.W., Innerarity T.L., Rall S.C. Jr., Weisgraber K.H. Plasma lipoproteins: apolipoprotein structure and function. J. Lipid Res. 25:1984;1277-1294.
150. Mann D.M.A., Pickering-Brown S.M., Siddons M.A., Iwatsubo T., Ihara Y., Asamiodaka A., Suzuki N., Asami-Odaka A. The extent of amyloid deposition in brain in patients with Down's syndrome does not depend upon the apolipoprotein E genotype. Neurosci. Lett. 196:1995;105-108.
151. Marder K., Maestre G., Cote L., Mejia H., Alfaro B., Halim A., Tang M., Tycko B., Mayeux R. The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia. Neurology. 44:1994;1330-1331.
152. Martinoli M.G., Trojanowski J.Q., Schmidt M.L., Arnold S.E., Fujiwara T.M., Lee V.M.Y., Hurtig H., Julien J.P., Clark C. Association of apolipoprotein epsilon-4 allele and neuropathologic findings in patients with dementia. Acta Neuropathol. 90:1995;239-243.
153. Masliah E., Mallory M., Ge N., Mucke L. Synaptic regeneration in hAPP695 transgenic and APOE knockout mice. Neuropathology. 44:1995;405-414.
154. Masliah E., Mallory M., Ge N.F., Alford M., Veinbergs I., Roses A.D. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136:1995;107-122.
155. Masliah E., Samuel W., Veinbergs I., Mallory M., Mante M., Saitoh T. Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain Res. 751:1997;307-314.
156. Matthews D.A., Cotman C., Lynch G. An electron microscopic study of lesion-induced synaptogenesis in the dentate gyrus of the adult rat: II. Reappearance of morphologically normal synaptic contacts. Brain Res. 115:1976;23-41.
157. May P.C., Finch C.E. Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration. Trends Neurosci. 15:1992;391-396.
158. May P.C., Lampert-Etchells M., Johnson S.A., Poirier J., Masters J.N., Finch C.E. Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat. Neuron. 5:1990;831-839.
159. May P.C., Robison P., Fuson K., Smalstig B., Stephenson D., Clemens J.A. Sulfated glycoprotein-2 expression increases in rodent brain after transient global ischemia. Mol. Brain Res. 15:1992;33-39.
160. Mayeux R., Stern Y., Ottman R., Tatemichi T.K., Tang M.X., Maestre G., Ngai C., Tycko B., Ginsberg H. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann. Neurol. 34:1993;752-754.
161. McConathy W.J., Alaupovic P. Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system. FEBS Lett. 37:1973;178-182.
162. McGeer P.L., Kawamata T., Walker D.G. Distribution of clusterin in Alzheimer brain tissue. Brain Res. 579:1992;337-341.
163. Meresse S., Delbart C., Fruchart J.C., Cecchelli R. Low-density lipoprotein receptor on endothelium of brain capillaries. J. Neurochem. 53:1989;340-345.
164. Metzger R.E., LaDu M.J., Pan J.B., Getz G.S., Frail D.E., Falduto M.T. Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:1996;372-380.
165. Michel D., Chabot J.G., Moyse E., Danik M., Quirion R. Possible functions of a new genetic marker in central nervous system: the sulfated glycoprotein-2 (SGP-2). Synapse. 11:1992;105-111.
166. Mockel B., Zinke H., Flach R., Weiss B., Weiler-Guttler H., Gassen H.G. Expression of apolipoprotein A-I in porcine brain endothelium in vitro. J. Neurochem. 62:1994;788-798.
167. Moestrup S.K., Gliemann J., Pallesen G. Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res. 269:1992;375-382.
168. C.M. Morris, H.M. Massey, R. Benjamin, A. Leake, C. Broadbent, M. Griffiths, H. Lamb, A. Brown, P.G. Ince, S. Tyrer, P. Thompson, I.G. McKeith, J.A. Edwardson, R.H. Perry, E.K. Perry, Molecular biology of apoE alleles in Alzheimer's and non-Alzheimer's dementias, J. Neural Trans., Suppl. (1996) 205-1218.
169. Mui S., Rebeck G.W., Mckennayasek D., Hyman B.T., Brown R.H. Apolipoprotein E epsilon-4 is not associated with earlier age at onset in amylotrophic lateral sclerosis. Ann. Neurol. 38:1995;460-463.
170. Murakami M., Ushio Y., Morino Y., Ohta T., Matsukado Y. Immunohistochemical localization of apolipoprotein E in human glial neoplasms. J. Clin. Invest. 82:1988;177-188.
171. Muramatsu T., Higuchi S., Arai H., Sasaki H., Yamada K., Hayashida M., Trojanowski J.Q. Apolipoprotein E epsilon-4 allele distribution in alcoholic dementia and in Alzheimer's disease in Japan. Ann. Neurol. 36:1994;797-799.
172. Nagy Z., Esiri M.M., Jobst K.A., Johnston C., Litchfield S., Sim E., Smith A.D. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience. 69:1995;757-761.
173. Nakagawa Y., Kitamoto T., Furukawa H., Ogomori K., Tateishi J. Apolipoprotein E in Creutzfeldt-Jakob disease. Lancet. 345:1995;68-68.
174. Nakai M., Kawamata T., Taniguchi T., Maeda K., Tanaka C. Expression of apolipoprotein E mRNA in rat microglia. Neurosci. Lett. 211:1996;41-44.
175. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:1991;163-166.
176. Namba Y., Tsuchiya H., Ikeda K. Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's disease. Neurosci. Lett. 134:1992;264-266.
177. Nathan B.P., Bellosta S., Sanan D.A., Weisgraber K.H., Mahley R.W., Pitas R.E. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 264:1994;850-852.
178. Nitsch R.M., Blusztajn J.K., Pittas A.G., Slack B.E., Growdon J.H., Wurtman R.J. Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl. Acad. Sci. U.S.A. 89:1992;1671-1675.
179. Novak S., Hiesberger T., Schneider W.J., Nimpf J. A new low density lipoprotein receptor homologue with 8 ligand binding repeats in brain of chicken and mouse. J. Biol. Chem. 271:1996;11732-11736.
180. O'Bryan M.K., Cheema S.S., Bartlett P.F., Murphy B.F., Pearse M.J. Clusterin levels increase during neuronal development. J. Neurobiol. 24:1993;421-432.
181. Ohm T.G., Kirca M., Bohl J., Scharnagl H., Gross W., Marz W. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience. 66:1995;583-587.
182. Okuizumi K., Onodera O., Namba Y., Ikeda K., Yamamoto T., Seki K., Ueki A., Nanko S., Tanaka H., Takahashi H., Oyanagi K., Mizusawa H., Kanazawa I., Tsuji S. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nat. Genet. 11:1995;207-209.
183. Okuizumi K., Onodera O., Seki K., Tanaka H., Namba Y., Ikeda K., Saunders A.M., Pericak-Vance M.A., Roses A.D., Tsuji S. Lack of association of very low density lipoprotein receptor gene polymorphism with Caucasian Alzheimer's disease. Ann. Neurol. 40:1996;251-254.
184. Okuizumi K., Onodera O., Tanaka H., Kobayashi H., Tsuji S., Takahashi H., Oyanagi K., Seki K., Tanaka M., Naruse S., Miyatake T., Mizusawa H., Kanazawa I. ApoE-ε4 and early-onset Alzheimer's. Nat. Genet. 7:1994;10-11.
185. Okumura T., Taylor I.L., Fukagawa K., Tso P., Pappas T.N. Apolipoprotein A-IV acts centrally in the brain to reduce the severity of gastric ulceration in the rat. Brain Res. 673:1995;153-156.
186. Olichney J.M., Hansen L.A., Galasko D., Saitoh T., Hofstetter C.R., Katzman R., Thal L.J. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology. 47:1996;190-196.
187. Ong W.Y., He Y., Suresh S., Patel S.C. Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus. Neuroscience. 79:1997;359-367.
188. Oyama F., Shimada H., Oyama R., Ihara Y. Apolipoprotein E genotype, Alzheimer's pathologies and related gene expression in the aged population. Mol. Brain Res. 29:1995;92-98.
189. Parker C.A., Callahan M.J., Lipinski W.J., Bisgaier C.L., Walker L.C. Effects of aging on glial and neural markers in apolipoprotein E-deficient mice. Soc. Neurosci. Abstr. 22:1996;207.
190. Pasinetti G.M., Cheng H.W., Morgan D.G., Lampert-Etchells M., McNeill T.H., Finch C.E. Astrocytic messenger RNA responses to striatal deafferentation in male rat. Neuroscience. 53:1993;199-211.
191. Pasinetti G.M., Finch C.E. Sulfated glycoprotein-2 (SGP-2) mRNA is expressed in rat striatal astrocytes following ibotenic acid lesions. Neurosci. Lett. 130:1991;1-4.
192. Pasinetti G.M., Johnson S.A., Oda T., Rozovsky I., Finch C.E. Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J. Comp. Neurol. 339:1994;387-400.
193. Patel S.C., Asotra K., Patel Y.C., McConathy W.J., Patel R.C., Suresh S. Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D. Neuroreport. 6:1995;653-657.
194. Payami H., Montee K.R., Kaye J.A., Bird T.D., Yu C.E., Wijsman E.M., Schellenberg G.D. Alzheimer's disease, apolipoprotein E4, and gender. JAMA. 271:1994;1316-1317.
195. Payami H., Zareparsi S., Montee K.R., Sexton G.J., Kaye J.A., Bird T.D., Yu C.E., Wijsman E.M., Heston L.L., Litt M., Schellenberg G.D. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am. J. Hum. Genet. 58:1996;803-811.
196. Pericak-Vance M.A., Bass M.P., Yamaoka L.H., Gaskell P.C., Scott W.K., Terwedow H.A., Menold M.M., Conneally P.M., Small G.W., Vance J.M., Saunders A.M., Roses A.D., Haines J.L. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA. 278:1997;1237-1241.
197. Pericak-Vance M.A., Bebout J.L., Gaskell P.C. Jr., Yamaoka L.H., Hung W.Y., Alberts M.J., Walker A.P., Bartlett R.J., Haynes C.A., Welsh K.A., Earl N.L., Heyman A., Clark C.M., Roses A.D. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am. J. Hum. Genet. 48:1991;1034-1050.
198. Perry E.K., Gibson P.H., Blessed G., Perry R.H., Tomlinson B.E. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J. Neurol. Sci. 34:1977;247-265.
199. Pickering-Brown S.M., Mann D.M.A., Bourke J.P., Roberts D.A., Balderson D., Burns A., Byrne J., Owen F. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases. Lancet. 343:1994;1155-1155.
200. Pickering-Brown S.M., Mann D.M.A., Owen F., Ironside J.W., de Silva R., Roberts D.A., Balderson D.J., Cooper P.N. Allelic variations in apolipoprotein E and prion protein genotype related to plaque formation and age of onset in sporadic Creutzfeldt-Jakob disease. Neurosci. Lett. 187:1995;127-129.
201. Pickering-Brown S.M., Siddons M., Mann D.M.A., Owen F., Neary D., Snowden J.S. Apolipoprotein E allelic frequencies in patients with lobar atrophy. Neurosci. Lett. 188:1995;205-207.
202. Pitas R.E., Boyles J.K., Lee S.H., Foss D., Mahley R.W. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta. 917:1987;148-161.
203. Pitas R.E., Boyles J.K., Lee S.H., Hui D., Weisgraber K.H. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain. J. Biol. Chem. 262:1987;14352-14360.
204. Pïrttila T., Mehta P.D., Soininen H., Kim K.S., Heinonen O., Paljarvi L., Kosunen O., Riekkinen P. Sr., Wisniewski H.M. Cerebrospinal fluid concentrations of soluble amyloid beta- protein and apolipoprotein E in patients with Alzheimer's disease: correlations with amyloid load in the brain. Arch. Neurol. 53:1996;189-193.
205. Pïrttila T., Soininen H., Heinonen O., Lehtimäki T., Bogdanovic N., Paljarvi L., Kosunen O., Winblad B., Riekkinen P., Wisniewski H.M., Mehta P.D. Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls. Brain Res. 722:1996;71-77.
206. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., Rubin E.M., Breslow J.L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:1992;343-353.
207. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17:1994;525-530.
208. J. Poirier, Neurobiology of apolipoprotein E in the normal brain and in Alzheimer's disease, in: K. Iqbal, B. Winblad, T. Nishimura, M. Takeda, H.M. Wisniewski (Eds.), Alzheimer's Disease: Biology, Diagnosis and Therapeutics, Wiley, 1997, pp. 93-101.
209. Poirier J., Baccichet A., Dea D., Gauthier S. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience. 55:1993;81-90.
210. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 342:1993;697-699.
211. Poirier J., Delisle M.-C., Quirion R., Aubert I., Farlow M.R., Lahiri D., Hui S., Bertrand P., Nalbantoglu J., Gilfix B.M., Gauthier S. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 92:1995;12260-12264.
212. J. Poirier, M.-C. Delisle, R. Quirion, I. Aubert, J. Rochford, I. Rousse, S. Gracon, M.R. Farlow, S. Gauthier, Apolipoprotein E4, cholinergic integrity, synaptic plasticity and Alzheimer's disease, in: A.D. Roses, K.H. Weisgraber, Y. Christen (Eds.), Apolipoprotein E and Alzheimer's Disease, Springer, Berlin, 1996, pp. 20-28.
213. Poirier J., Hess M., May P.C., Finch C.E. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol. Brain Res. 11:1991;97-106.
214. J. Poirier, M. Hess, P.C. May, G.M. Pasinetti, C.E. Finch, Astroglial gene expression during reactive synaptogenesis. In: T. Nagatsu (Ed.), Basic and Therapeutic Strategies in Alzheimer's and Parkinson's diseases, Plenum, New York, 1990, pp. 191-194.
215. Polvikoski T., Sulkava R., Haltia M., Kainulainen K., Vuorio A., Verkkoniemi A., Niinisto L., Halonen P., Kontula K. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. New Engl. J. Med. 333:1995;1242-1247.
216. Popko B., Goodrum J.F., Bouldin T.W., Zhang S.H., Maeda N. Nerve regeneration occurs in the absence of apolipoprotein E in mice. J. Neurochem. 60:1993;1155-1158.
217. Pritchard M.L., Saunders A.M., Gaskell P.C., Small G.W., Conneally P.M., Rosi B., Yamaoka L.H., Roses A.D., Haines J.L., Pericak-Vance M.A. No association between very low density lipoprotein receptor (VLDL-R) and Alzheimer disease in American Caucasians. Neurosci. Lett. 209:1996;105-108.
218. Provost P.R., Tremblay Y., el-Amine M., Belanger A. Guinea pig apolipoprotein D RNA diversity, and developmental and gestational modulation of mRNA levels. Mol. Cell. Endocrinol. 109:1995;225-236.
219. Provost P.R., Villeneuve L., Weech P.K., Milne R.W., Marcel Y.L., Rassart E. Localization of the major sites of rabbit apolipoprotein D gene transcription by in situ hybridization. J. Lipid Res. 32:1991;1959-1970.
220. Provost P.R., Weech P.K., Tremblay N.M., Marcel Y.L., Rassart E. Molecular characterization and differential mRNA tissue distribution of rabbit apolipoprotein D. J. Lipid Res. 31:1990;2057-2065.
221. Rall S.C. Jr., Weisgraber K.H., Innerarity T.L., Mahley R.W. Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc. Natl. Acad. Sci. U.S.A. 79:1982;4696-4700.
222. Rall S.C. Jr., Weisgraber K.H., Mahley R.W., Human apolipoprotein E. The complete amino acid sequence. J. Biol. Chem. 257:1982;4171-4178.
223. Rebeck G.W., Harr S.D., Strickland D.K., Hyman B.T. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann. Neurol. 37:1995;211-217.
224. Rebeck G.W., Perls T.T., West H.L., Sodhi P., Lipsitz L.A., Hyman B.T. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology. 44:1994;1513-1516.
225. Rebeck G.W., Reiter J.S., Strickland D.K., Hyman B.T. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 11:1993;575-580.
226. Reed T., Carmelli D., Swan G.E., Breitner J.C., Welsh K.A., Jarvik G.P., Deeb S., Auwerx J. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele. Arch. Neurol. 51:1994;1189-1192.
227. Reiman E.M., Caselli R.J., Yun L.S., Chen K., Bandy D., Minoshima S., Thibodeau S.N., Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. New Engl. J. Med. 334:1996;752-758.
228. Riekkinen P., Soininen H., Partanen K., Paakkonen A., Helisalmi S., Riekkinen P. Sr. The ability of THA treatment to increase cortical alpha waves is related to apolipoprotein E genotype of Alzheimer disease patients. Psychopharmacology. 129:1997;285-288.
229. Robinson P.J., Rapoport S.I. A method for examining turnover and synthesis of palmitate-containing brain lipids in vivo. Clin. Exp. Pharmacol. Physiol. 16:1989;701-714.
230. Roheim P.S., Carey M., Forte T., Vega G.L. Apolipoproteins in human cerebrospinal fluid. Proc. Natl. Acad. Sci. U.S.A. 76:1979;4646-4649.
231. Rosenberg M.E., Dvergsten J., Correa-Rotter R. Clusterin: an enigmatic protein recruited by diverse stimuli. J. Lab. Clin. Med. 121:1993;205-214.
232. Roses A.D. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu. Rev. Med. 47:1996;387-400.
233. Royston M.C., Mann D.M.A., Pickering-Brown S.M., Owen F., Perry R., Raghavan R., Khinnu C., Tyrer S., Day K., Crook R., Hardy J., Roberts G.W. Apolipoprotein E epsilon-2 allele promotes longevity and protects patients with Down's syndrome from dementia. Neuroreport. 5:1994;2583-2585.
234. Rozovsky I., Stone D.J., Morgan T.E., Hajian H., Finch C.E. Microglial apoE is regulated by estrogen and TGFβ-1: role of cell-cell interactions. Soc. Neurosci. Abstr. 23:1997;1653.
235. Rubinsztein D.C., Hanlon C.S., Irving R.M., Goodburn S., Evans D.G., Kellar-Wood H., Xuereb J.H., Bandmann O., Harding A.E. Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease. Mol. Cell. Probes. 8:1994;519-525.
236. Sakai M., Miyazaki A., Hakamata H., Kodama T., Suzuki H., Kobori S., Shichiri, Horiuchi S. The scavenger receptor serves as a route for internalization of lysophosphatidylcholine in oxidized low density lipoprotein-induced macrophage proliferation. J. Biol. Chem. 271:1996;27346-27352.
237. Sakoda S., Kuriyama M., Osame M., Takahashi K., Yamano T., Sasaki J., Matsunaga A. Apolipoprotein E epsilon-4. Neurology. 44:1994;2420-2420.
238. Salen G., Berginer V., Shore V., Horak I., Horak E., Tint G.S., Shefer S. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid. New Engl. J. Med. 316:1987;1233-1238.
239. Salvatore M., Seeber A.C., Nacmias B., Petraroli R., Dalessandro M., Sorbi S., Pocchiari M. Apolipoprotein E in sporadic and familial Creutzfeldt-Jakob disease. Neurosci. Lett. 199:1995;95-98.
240. Samuel W., Masliah E., Hill L.R., Butters N., Terry R. Hippocampal connectivity and Alzheimer's dementia: effects of synapse loss and tangle frequency in a two-component model. Neurology. 44:1994;2081-2088.
241. Saunders A.M., Schmader K., Breitner J.C., Benson M.D., Brown W.T., Goldfarb L., Goldgaber D., Manwaring M.G., Szymanski M.H., McCown N., Dole K.C., Schmechel D.E., Strittmatter W.J., Pericak-Vance M.A., Roses A.D. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet. 342:1993;710-711.
242. Saunders A.M., Strittmatter W.J., Schmechel D.E., St. George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
243. Schaeren-Wiemers N., Schaefer C., Valenzuela D.M., Yancopoulos G.D., Schwab M.E. Identification of new oligodendrocyte- and myelin-specific genes by a differential screening approach. J. Neurochem. 65:1995;10-22.
244. Scheff S.W., Benardo L.S., Cotman C.W. Decline in reactive fiber growth in the dentate gyrus of aged rats compared to young adult rats following entorhinal cortex removal. Brain Res. 199:1980;21-38.
245. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., Pericak-Vance M.A., Goldgaber D., Roses A.D. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90:1993;9649-9653.
246. L.S. Schneider, M.R. Farlow, J.M. Pogoda, J. Poirier, Interaction of estrogen replacement therapy and apolipoprotein E genotype status on response to cholinesterase inhibitor therapy in Alzheimer's disease, in: K. Iqbal, B. Winblad, M. Takeda, H.M. Wisniewski (Eds.), Alzheimer's disease: Biology, Diagnosis and Therapeutics, Wiley, New York, 1997, pp. 655-659.
247. Seguin D., Desforges M., Rassart E. Molecular characterization and differential mRNA tissue distribution of mouse apolipoprotein D. Mol. Brain Res. 30:1995;242-250.
248. Senut M.C., Jazat F., Choi N.H., Lamour Y. Protein SP40,40-like immunoreactivity in the rat brain: progressive increase with age. Eur. J. Neurol. 4:1992;917-928.
249. Shen P., Howlett G.J. Two coding regions closely linked to the rat apolipoprotein E gene: nucleotide sequences of rat apolipoprotein C-I and ECL cDNA. Arch. Biochem. Biophys. 297:1992;345-353.
250. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.F., Bruni A.C., Montesi M.P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R.J., Wasco W., Da Silva H.A.R., Haines J.L., Pericak-Vance M.A., Tanzi R.E., Roses A.D., Fraser P.E., Rommens J.M., St. George-Hyslop P.H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
251. Simonet W.S., Bucay N., Pitas R.E., Lauer S.J., Taylor J.M. Multiple tissue-specific elements control the apolipoprotein E/C-I gene locus in transgenic mice. J. Biol. Chem. 266:1991;8651-8654.
252. Skoog I., Hesser C., Fredman P., Andreasson L.A., Palmertz B., Blennow K. Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions. Arch. Neurol. 54:1997;267-272.
253. Small G.W., Mazziotta J.C., Collins M.T., Baxter L.R., Phelps M.E., Mandelkern M.A., Kaplan A., La Rue A., Adamson C.F., Chang L., Guze B.H., Corder E.H., Saunders A.M., Haines J.L., Pericak-Vance M.A., Roses A.D. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA. 273:1995;942-947.
254. Smith A.D., Jobst K.A., Johnston C., Joachim C., Nagy Z. Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease. Lancet. 348:1996;483-484.
255. Smith K.M., Lawn R.M., Wilcox J.N. Cellular localization of apolipoprotein D and lecithin: cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization. J. Lipid Res. 31:1990;995-1004.
256. Snipes G.J., McGuire C.B., Norden J.J., Freeman J.A. Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells. Proc. Natl. Acad. Sci. U.S.A. 83:1986;1130-1134.
257. Soininen H., Kosunen O., Helisalmi S., Mannermaa A., Paljarvi L., Talasniemi S., Ryynanen M., Riekkinen P. Sr. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele. Neurosci. Lett. 187:1995;79-82.
258. Soininen H., Partanen K., Pitkanen A., Hallikainen M., Hanninen T., Helisalmi S., Mannermaa A., Ryynanen M., Koivisto K., Riekkinen P. Sr. Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele. Neurology. 45:1995;391-392.
259. Spreyer P., Schaal H., Kuhn G., Rothe T., Unterbeck A., Olek K., Muller H.W. Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve. EMBO J. 9:1990;2479-2484.
260. St Clair D., Norrman J., Perry R., Yates C., Wilcock G., Brookes A. Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. Neurosci. Lett. 176:1994;45-46.
261. St. George-Hyslop P.H., McLachlan D.C., Tsuda T., Rogaev E., Karlinsky H., Lippa C.F., Pollen D. Alzheimer's disease and possible gene interaction. Science. 263:1994;537-537.
262. Stern Y., Brandt J., Albert M., Jacobs D.M., Liu X., Bell K., Marder K., Sano M., Albert S., Del-Castillo Castenada C., Bylsma F., Tycko B., Mayeux R. The absence of an apolipoprotein ε4 allele is associated with a more aggressive form of Alzheimer's disease. Ann. Neurol. 41:1997;615-620.
263. Steward O., Scoville S.A. Cells of origin of entorhinal cortical afferents to the hippocampus and facia dentata of the rat. J. Comp. Neurol. 169:1995;347-370.
264. Steyrer E., Kostner G.M. Activation of lecithin-cholesterol acyltransferase by apolipoprotein D: comparison of proteoliposomes containing apolipoprotein D, A-I or C-I. Biochim. Biophys. Acta. 958:1988;484-491.
265. Stoll G., Meuller H.W., Trapp B.D., Griffin J.W. Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve. GLIA. 2:1989;170-176.
266. Stone D.J., Rozovsky I., Morgan T.E., Anderson C.P., Hajian H., Finch C.E. Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp. Neurol. 143:1997;313-318.
267. Strittmatter W.J., Saunders A.M., Schmechel D.E., Pericak-Vance M.A., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90:1993;1977-1981.
268. Suzuki H., Kurihara Y., Takeya M., Kamada N., Kataoka M., Jishage K., Ueda O., Sakaguchi H., Higashi T., Suzuki T., Takashima Y., Kawabe Y., Cynshi O., Wada Y., Honda M., Kurihara H., Aburatani H., Doi T., Matsumoto A., Azuma S., Noda T., Toyoda Y., Itakura H., Yazaki Y., Horiuchi S., Takahashi K., Kar Kruijt J., van Berkel T.J., Steinbrecher U.P., Ishibashi S., Maeda N., Gordon S., Kodama T. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 386:1997;292-296.
269. Svennerholm L., Gottfries C.G. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J. Neurochem. 62:1994;1039-1047.
270. Swaney J.B., Weisgraber K.H. Effect of apolipoprotein C-I peptides on the apolipoprotein E content and receptor-binding properties of beta-migrating very low density lipoproteins. J. Lipid Res. 35:1994;134-142.
271. Swanson L.W., Simmons D.M., Hofmann S.L., Goldstein J.L., Brown M.S. Localization of mRNA for low density lipoprotein receptor and a cholesterol synthetic enzyme in rabbit nervous system by in situ hybridization. Proc. Natl. Acad. Sci. U.S.A. 85:1988;9821-9825.
272. Talbot C., Lendon C.L., Craddock N., Shears S., Morris J.C., Goate A. Protection against Alzheimer's disease with apoE epsilon 2. Lancet. 343:1994;1432-1433.
273. Terpstra V., Kondratenko N., Steinberg D. Macrophages lacking scavenger receptor A show a decrease in binding and uptake of acetylated low-density lipoprotein and of apoptotic thymocytes, but not of oxidatively damaged red blood cells. Proc. Natl. Acad. Sci. U.S.A. 94:1997;8127-8131.
274. Teter B., Soorya N., Beech W., Harris-White M.E., Frautschy S.A., Cole G.M. Estrogen regulation of apolipoprotein E in microglia and in relation to neuronal sprouting. Soc. Neurosci. Abstr. 23:1997;1653.
275. Tooyama I., Kawamata T., Akiyama H., Kimura H., Moestrup S.K., Gliemann J., Matsuo A., McGeer P.L. Subcellular localization of the low density lipoprotein receptor-related protein (alpha(2)-macroglobulin receptor) in human brain. Brain Res. 691:1995;235-238.
276. Tycko B., Feng L., Nguyen L., Francis A., Hays A., Chung W.Y., Tang M.X., Stern Y., Sahota A., Hendrie H., Mayeux R. Polymorphisms in the human apolipoprotein-J/clusterin gene: ethnic variation and distribution in Alzheimer's disease. Hum. Genet. 98:1996;430-436.
277. Utermann G., Langenbeck U., Beisiegel U., Weber W. Genetics of the apolipoprotein E system in man. Am. J. Hum. Genet. 32:1980;339-347.
278. Van Broeckhoven C., Backhovens H., Cruts M., Martin J.J., Crook R., Houlden H., Hardy J. APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci. Lett. 169:1994;179-180.
279. van Duijn C.M., de Knijff P., Cruts M., Wehnert A., Havekes L.M., Hofman A., Van Broeckhoven C. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat. Genet. 7:1994;74-78.
280. van Gool W.A., Evenhuis H.M., van Duijn C.M. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing. Ann. Neurol. 38:1995;225-230.
281. Weiler-Guttler H., Sommerfeldt M., Papandrikopoulou A., Mischek U., Bonitz D., Frey A., Grupe M., Scheerer J., Gassen H.G. Synthesis of apolipoprotein A-1 in pig brain microvascular endothelial cells. J. Neurochem. 54:1990;444-450.
282. Weisgraber K.H. Apolipoprotein E: structure-function relationships. Adv. Protein Chem. 45:1994;249-302.
283. Weisgraber K.H., Innerarity T.L., Mahley R.W. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J. Biol. Chem. 257:1982;2518-2521.
284. Weisgraber K.H., Roses A.D., Strittmatter W.J. The role of apolipoprotein E in the nervous system. Curr. Opin. Lipidology. 5:1994;110-116.
285. West H.L., Rebeck G.W., Hyman B.T. Frequency of the apolipoprotein E ε2 allele is diminished in sporadic Alzheimer disease. Neurosci. Lett. 175:1994;46-48.
286. Whitehead A.S., Bertrandy S., Finnan F., Butler A., Smith G.D., Benshlomo Y. Frequency of the apolipoprotein E epsilon-4 allele in a case-control study of early onset Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 61:1996;347-351.
287. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., Delon M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;1237-1239.
288. Williams S.E., Kounnas M.Z., Argraves K.M., Argraves W.S., Strickland D.K. The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and the receptor-associated protein. An overview. Ann. NY Acad. Sci. 737:1994;1-13.
289. Willnow T.E., Goldstein J.L., Orth K., Brown M.S., Herz J. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J. Biol. Chem. 267:1992;26172-26180.
290. Wisniewski T., Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135:1992;235-238.
291. Wisniewski T., Morelli L., Wegiel J., Levy E., Wisniewski H.M., Frangione B. The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's Syndrome. Ann. Neurol. 37:1995;136-138.
292. Wolf B.B., Lopes M.B., VandenBerg S.R., Gonias S.L. Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. Am. J. Pathol. 141:1992;37-42.
293. Wu E., Brosnan C.F., Raine C.S. SP-40,40 immunoreactivity in inflammatory CNS lesions displaying astrocyte/oligodendrocyte interactions. J. Neuropathol. Exp. Neurol. 52:1993;129-134.
294. Xu P.T., Schmechel D., Rothrockchristian T., Burkhart D.S., Qiu H.L., Popko B., Sullivan P., Maeda N., Saunders A.M., Roses A.D., Gilbert J.R. Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice-human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol. Dis. 3:1996;229-245.
295. Yamazaki H., Bujo H., Kusunoki J., Seimiya K., Kanaki T., Morisaki N., Schneider W.J., Saito Y. Elements of neural adhesion molecules and a yeast vacuolar protein sorting receptor are present in a novel mammalian low density lipoprotein receptor family member. J. Biol. Chem. 271:1996;24761-24768.
296. Zerr I., Helmhold M., Armstrong V.W., Weber T. Apolipoprotein E in Creutzfeldt-Jakob disease. Lancet. 345:1995;68-69.
297. Zerr I., Helmhold M., Poser S., Armstrong V.W., Weber T. Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeldt-Jakob disease. Arch. Neurol. 53:1996;1233-1238.
298. Zheng G., Bachinsky D.R., Stamenkovic I., Strickland D.K., Brown D., Andres G., McCluskey R.T. Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP). J. Histochem. Cytochem. 42:1994;531-542.
299. Zubenko G.S., Stiffler S., Stabler S., Kopp U., Hughes H.B., Cohen B.M.,
300. Zuliani G., Hobbs H.H. Tetranucleotide length polymorphism 5′ of the alpha 2- macroglobulin receptor (A2MR)/LDL receptor-related protein (LRP) gene. Hum. Mol. Genet. 3:1994;215-215.
301. Zwain I.H., Grima J., Cheng C.Y. Regulation of clusterin secretion and mRNA expression in astrocytes by cytokines. Mol. Cell. Neurosci. 5:1994;229-237.